PATENT CLAIM ANALYSIS

Application Number: 15891974
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-04
Patent Classification: ["514", "170000"]

Abstract:
Disclosed are methods of treating prostate cancer by administering abiraterone acetate plus prednisone with androgen deprivation therapy.

Claim (Index 3):
A method of  claim 1 , wherein the androgen deprivation therapy comprises an orchiectomy.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14380606', '15013660', '14523333', '15551708', '15704726']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7868751141264082
- 35 USC 102 Novelty (BERT): 0.5339431513906211
- Combined Prediction Score: 0.7615819178528295
- Mean Citation Score: 337.223654
- Max Citation Score: 364.2922
- Similarity Product: 302.7852167644024

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test